Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines.

作者: G. R. Martin , P. Leff , D. Cambridge , V. J. Barrett

DOI: 10.1007/BF00164867

关键词:

摘要: Two receptors mediating relaxant responses to 5-hydroxytryptamine (5-HT) were studied comparatively in rings of rabbit jugular vein contracted with U-46619 (10 nmol/l). At low concentrations 5-HT (0.001–0.1 μmol/l) vascular relaxation was mediated indirectly by the endothelial receptor previously described Leff et al. (1987). In preparations denuded endothelium, higher amine (0.03–30 caused directly, presumably via a located on smooth muscle cells. Similarity between evident that both susceptible antagonism methysergide, but resistant blockade ketanserin and MDL 72222. these respects, qualified for ‘5-HT1-like’ classification. Consistent this, 5-carboxamidotryptamine demonstrated agonist potency than at directly. However, endothelium-intact this order reversed, showing did not satisfy completely criteria designation. When activities single set tryptamines compared -denuded rings, different affinity relative efficacy estimates obtained, confirming two distinct mediate tissue. The most striking difference types α-methyl-5-HT since it expressed high comparable receptor, inactive endothelium-denuded up 30 μmol/l. antagonist studies, butyrophenone spiperone (1 μol/l) likewise distinguished types, failed block endothelium-dependent relaxations, an 8-fold parallel, rightward displacement concentration-effect curve obtained preparations. possibility one or might vasodepressor vivo investigated pentobarbitone-anaesthetised rats treated ketanserin. hypotensive potencies showed close agreement their affinities type directly relaxation, endothelium. mg/kg, i. v.) antagonised response 5-carboxamidotryptamine, causing 10-fold right-shift dose-effect curve. These results further support utility as probes classification and, addition, suggest they can be used differential well vitro.

参考文章(32)
Michael A. Trevethick, Wasyl Feniuk, Patrick P.A. Humphrey, 5-hydroxytryptamine-induced relaxation of neonatal porcine vena cava in vitro Life Sciences. ,vol. 35, pp. 477- 486 ,(1984) , 10.1016/0024-3205(84)90240-6
J. R. VANE, The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation. British journal of pharmacology and chemotherapy. ,vol. 14, pp. 87- 98 ,(1959) , 10.1111/J.1476-5381.1959.TB00933.X
J.W. Black, P. Leff, N.P. Shankley, J. Wood, An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation British Journal of Pharmacology. ,vol. 84, pp. 561- 571 ,(1985) , 10.1111/J.1476-5381.1985.TB12941.X
M. G�thert, P. Kollecker, N. Rohm, H. -R. Zerkowski, Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 332, pp. 317- 323 ,(1986) , 10.1007/BF00500081
H.E. Connor, W. Feniuk, P.P.A. Humphrey, M.J. Perren, 5-Carboxamidotryptamine is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetized cats. British Journal of Pharmacology. ,vol. 87, pp. 417- 426 ,(1986) , 10.1111/J.1476-5381.1986.TB10832.X
G. Engel, M. G�thert, E. M�ller-Schweinitzer, E. Schlicker, L. Sistonen, P. A. Stadler, Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 324, pp. 116- 124 ,(1983) , 10.1007/BF00497016
Yuji Imaizumi, Miyabi Baba, Yoshiko Imaizumi, Minoru Watanabe, Involvement of endothelium in the relaxation of isolated chick jugular vein by 5-hydroxytryptamine European Journal of Pharmacology. ,vol. 97, pp. 335- 336 ,(1984) , 10.1016/0014-2999(84)90472-2
W. Feniuk, P.P.A. Humphrey, A.D. Watts, 5-hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle European Journal of Pharmacology. ,vol. 96, pp. 71- 78 ,(1983) , 10.1016/0014-2999(83)90530-7